Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

14 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Neuroprotective Profile of Triazole Grandisin Analogue against Amyloid-Beta Oligomer-Induced Cognitive Impairment.
Andrade VHB, M Rodrigues EY, Dias NAF, Ferreira GFC, Carvalho DB, das Neves AR, Coronel PMV, Yonekawa MKA, Parisotto EB, Santos EAD, Souza AS, Paredes-Gamero EJ, de Sousa KS, Souza LL, Resstel LBM, Baroni ACM, Lagatta DC. Andrade VHB, et al. Among authors: baroni acm. ACS Chem Neurosci. 2023 Dec 20;14(24):4298-4310. doi: 10.1021/acschemneuro.3c00443. Epub 2023 Dec 4. ACS Chem Neurosci. 2023. PMID: 38048522
In Vivo Antileishmanial Effect of 3,5-Diaryl-isoxazole Analogues Based on Veraguensin, Grandisin, and Machilin G: A Glance at a Preclinical Study.
das Neves AR, Carvalho DB, Silva F, Rosalem RF, Pelizaro BI, Castilho PF, Oliveira KMP, Cassemiro NS, Pessatto LR, Paredes-Gamero EJ, Piranda EM, Silva DB, Arruda CCP, Baroni ACM. das Neves AR, et al. Among authors: baroni acm. ACS Infect Dis. 2023 May 12;9(5):1150-1159. doi: 10.1021/acsinfecdis.3c00090. Epub 2023 Apr 27. ACS Infect Dis. 2023. PMID: 37103973
Design, synthesis and antitrypanosomatid activity of 2-nitroimidazole-3,5-disubstituted isoxazole compounds based on benznidazole.
Carvalho DB, Costa PAN, Portapilla GB, das Neves AR, Shiguemoto CYK, Pelizaro BI, Silva F, Piranda EM, Arruda CCP, Gaspari PDM, Cardoso IA, Luccas PH, Nonato MC, Lopes NP, de Albuquerque S, Baroni ACM. Carvalho DB, et al. Among authors: baroni acm. Eur J Med Chem. 2023 Nov 15;260:115451. doi: 10.1016/j.ejmech.2023.115451. Epub 2023 May 5. Eur J Med Chem. 2023. PMID: 37573209
Design, synthesis and antitrypanosomatid activities of 3,5-diaryl-isoxazole analogues based on neolignans veraguensin, grandisin and machilin G.
Trefzger OS, das Neves AR, Barbosa NV, Carvalho DB, Pereira IC, Perdomo RT, Matos MFC, Yoshida NC, Kato MJ, de Albuquerque S, Arruda CCP, Baroni ACM. Trefzger OS, et al. Among authors: baroni acm. Chem Biol Drug Des. 2019 Mar;93(3):313-324. doi: 10.1111/cbdd.13417. Epub 2018 Nov 25. Chem Biol Drug Des. 2019. PMID: 30354012
Effect of isoxazole derivatives of tetrahydrofuran neolignans on intracellular amastigotes of Leishmania (Leishmania) amazonensis: A structure-activity relationship comparative study with triazole-neolignan-based compounds.
das Neves AR, Trefzger OS, Barbosa NV, Honorato AM, Carvalho DB, Moslaves IS, Kadri MCT, Yoshida NC, Kato MJ, Arruda CCP, Baroni ACM. das Neves AR, et al. Among authors: baroni acm. Chem Biol Drug Des. 2019 Dec;94(6):2004-2012. doi: 10.1111/cbdd.13609. Epub 2019 Sep 12. Chem Biol Drug Des. 2019. PMID: 31444858
Green Synthesis of Molecules for the Treatment of Neglected Diseases.
Anghinoni JM, Dilelio MC, Shiguemoto CYK, Schumacher RF, Baroni ACM, Lenardão EJ. Anghinoni JM, et al. Among authors: baroni acm. Curr Top Med Chem. 2023;23(11):1004-1041. doi: 10.2174/1568026623666230526161055. Curr Top Med Chem. 2023. PMID: 37246323 Review.
14 results